vs

Side-by-side financial comparison of Delek US Holdings, Inc. (DK) and Henry Schein (HSIC). Click either name above to swap in a different company.

Henry Schein is the larger business by last-quarter revenue ($3.4B vs $2.4B, roughly 1.4× Delek US Holdings, Inc.). Delek US Holdings, Inc. runs the higher net margin — 3.2% vs 2.9%, a 0.3% gap on every dollar of revenue. On growth, Henry Schein posted the faster year-over-year revenue change (7.7% vs 2.3%). Delek US Holdings, Inc. produced more free cash flow last quarter ($382.8M vs $338.0M). Over the past eight quarters, Henry Schein's revenue compounded faster (4.1% CAGR vs -11.9%).

Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. For 14 consecutive years, the company has been named as one of the World's Most Ethical Companies by Ethisphere, most recently in 2025.

DK vs HSIC — Head-to-Head

Bigger by revenue
HSIC
HSIC
1.4× larger
HSIC
$3.4B
$2.4B
DK
Growing faster (revenue YoY)
HSIC
HSIC
+5.4% gap
HSIC
7.7%
2.3%
DK
Higher net margin
DK
DK
0.3% more per $
DK
3.2%
2.9%
HSIC
More free cash flow
DK
DK
$44.8M more FCF
DK
$382.8M
$338.0M
HSIC
Faster 2-yr revenue CAGR
HSIC
HSIC
Annualised
HSIC
4.1%
-11.9%
DK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DK
DK
HSIC
HSIC
Revenue
$2.4B
$3.4B
Net Profit
$78.3M
$101.0M
Gross Margin
9.3%
30.9%
Operating Margin
6.8%
4.7%
Net Margin
3.2%
2.9%
Revenue YoY
2.3%
7.7%
Net Profit YoY
118.9%
7.4%
EPS (diluted)
$1.23
$0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DK
DK
HSIC
HSIC
Q4 25
$2.4B
$3.4B
Q3 25
$2.9B
$3.3B
Q2 25
$2.8B
$3.2B
Q1 25
$2.6B
$3.2B
Q4 24
$2.4B
$3.2B
Q3 24
$3.0B
$3.2B
Q2 24
$3.3B
$3.1B
Q1 24
$3.1B
$3.2B
Net Profit
DK
DK
HSIC
HSIC
Q4 25
$78.3M
$101.0M
Q3 25
$178.0M
$101.0M
Q2 25
$-106.4M
$86.0M
Q1 25
$-172.7M
$110.0M
Q4 24
$-413.8M
$94.0M
Q3 24
$-76.8M
$99.0M
Q2 24
$-37.2M
$104.0M
Q1 24
$-32.6M
$93.0M
Gross Margin
DK
DK
HSIC
HSIC
Q4 25
9.3%
30.9%
Q3 25
13.8%
30.7%
Q2 25
1.9%
31.4%
Q1 25
-2.4%
31.6%
Q4 24
-5.7%
31.1%
Q3 24
-0.7%
31.3%
Q2 24
0.5%
32.5%
Q1 24
3.0%
31.9%
Operating Margin
DK
DK
HSIC
HSIC
Q4 25
6.8%
4.7%
Q3 25
10.2%
4.9%
Q2 25
-1.2%
4.7%
Q1 25
-4.8%
5.5%
Q4 24
-17.0%
4.9%
Q3 24
-4.0%
4.9%
Q2 24
0.1%
5.1%
Q1 24
0.9%
4.7%
Net Margin
DK
DK
HSIC
HSIC
Q4 25
3.2%
2.9%
Q3 25
6.2%
3.0%
Q2 25
-3.8%
2.7%
Q1 25
-6.5%
3.5%
Q4 24
-17.4%
2.9%
Q3 24
-2.5%
3.1%
Q2 24
-1.1%
3.3%
Q1 24
-1.0%
2.9%
EPS (diluted)
DK
DK
HSIC
HSIC
Q4 25
$1.23
$0.85
Q3 25
$2.93
$0.84
Q2 25
$-1.76
$0.70
Q1 25
$-2.78
$0.88
Q4 24
$-6.48
$0.75
Q3 24
$-1.20
$0.78
Q2 24
$-0.58
$0.80
Q1 24
$-0.51
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DK
DK
HSIC
HSIC
Cash + ST InvestmentsLiquidity on hand
$625.8M
$156.0M
Total DebtLower is stronger
$3.2B
$2.3B
Stockholders' EquityBook value
$547.3M
$3.2B
Total Assets
$6.8B
$11.2B
Debt / EquityLower = less leverage
5.91×
0.71×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DK
DK
HSIC
HSIC
Q4 25
$625.8M
$156.0M
Q3 25
$630.9M
$136.0M
Q2 25
$615.5M
$145.0M
Q1 25
$623.8M
$127.0M
Q4 24
$735.6M
$122.0M
Q3 24
$1.0B
$126.0M
Q2 24
$657.9M
$138.0M
Q1 24
$753.4M
$159.0M
Total Debt
DK
DK
HSIC
HSIC
Q4 25
$3.2B
$2.3B
Q3 25
$3.2B
$2.2B
Q2 25
$3.1B
$2.1B
Q1 25
$3.0B
$2.0B
Q4 24
$2.8B
$1.8B
Q3 24
$2.8B
$1.9B
Q2 24
$2.5B
$1.9B
Q1 24
$2.5B
$2.0B
Stockholders' Equity
DK
DK
HSIC
HSIC
Q4 25
$547.3M
$3.2B
Q3 25
$444.8M
$3.4B
Q2 25
$294.9M
$3.4B
Q1 25
$429.4M
$3.3B
Q4 24
$575.2M
$3.4B
Q3 24
$875.4M
$3.5B
Q2 24
$982.8M
$3.5B
Q1 24
$1.0B
$3.6B
Total Assets
DK
DK
HSIC
HSIC
Q4 25
$6.8B
$11.2B
Q3 25
$7.1B
$11.1B
Q2 25
$7.1B
$10.9B
Q1 25
$6.9B
$10.5B
Q4 24
$6.7B
$10.2B
Q3 24
$7.0B
$10.6B
Q2 24
$6.9B
$10.3B
Q1 24
$7.2B
$10.1B
Debt / Equity
DK
DK
HSIC
HSIC
Q4 25
5.91×
0.71×
Q3 25
7.14×
0.64×
Q2 25
10.51×
0.61×
Q1 25
7.07×
0.59×
Q4 24
4.81×
0.54×
Q3 24
3.19×
0.54×
Q2 24
2.50×
0.54×
Q1 24
2.41×
0.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DK
DK
HSIC
HSIC
Operating Cash FlowLast quarter
$502.8M
$381.0M
Free Cash FlowOCF − Capex
$382.8M
$338.0M
FCF MarginFCF / Revenue
15.8%
9.8%
Capex IntensityCapex / Revenue
4.9%
1.3%
Cash ConversionOCF / Net Profit
6.42×
3.77×
TTM Free Cash FlowTrailing 4 quarters
$6.3M
$573.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DK
DK
HSIC
HSIC
Q4 25
$502.8M
$381.0M
Q3 25
$44.0M
$174.0M
Q2 25
$51.4M
$120.0M
Q1 25
$-62.4M
$37.0M
Q4 24
$-163.5M
$204.0M
Q3 24
$-21.6M
$151.0M
Q2 24
$-48.4M
$296.0M
Q1 24
$166.7M
$197.0M
Free Cash Flow
DK
DK
HSIC
HSIC
Q4 25
$382.8M
$338.0M
Q3 25
$-64.0M
$141.0M
Q2 25
$-114.4M
$88.0M
Q1 25
$-198.1M
$6.0M
Q4 24
$-354.0M
$168.0M
Q3 24
$-140.6M
$117.0M
Q2 24
$-128.3M
$259.0M
Q1 24
$128.4M
$156.0M
FCF Margin
DK
DK
HSIC
HSIC
Q4 25
15.8%
9.8%
Q3 25
-2.2%
4.2%
Q2 25
-4.1%
2.7%
Q1 25
-7.5%
0.2%
Q4 24
-14.9%
5.3%
Q3 24
-4.6%
3.7%
Q2 24
-3.9%
8.3%
Q1 24
4.1%
4.9%
Capex Intensity
DK
DK
HSIC
HSIC
Q4 25
4.9%
1.3%
Q3 25
3.7%
1.0%
Q2 25
6.0%
1.0%
Q1 25
5.1%
1.0%
Q4 24
8.0%
1.1%
Q3 24
3.9%
1.1%
Q2 24
2.4%
1.2%
Q1 24
1.2%
1.3%
Cash Conversion
DK
DK
HSIC
HSIC
Q4 25
6.42×
3.77×
Q3 25
0.25×
1.72×
Q2 25
1.40×
Q1 25
0.34×
Q4 24
2.17×
Q3 24
1.53×
Q2 24
2.85×
Q1 24
2.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DK
DK

Refining$2.2B91%
Other$173.0M7%
Gravity Water Intermediate Holdings LLC Gravity$22.5M1%
Related Party$20.8M1%
Logistics$1.3M0%

HSIC
HSIC

Global Dental Merchandise$1.2B35%
Global Medical$1.1B31%
Global Dental Equipment$536.0M16%
Global Specialty Products$422.0M12%
Global Technology$173.0M5%
Global Value Added Services$64.0M2%
Equity Method Investee$14.0M0%

Related Comparisons